Fabry Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth ...

As LB Pharmaceuticals enters a pivotal stage of growth, the additions of Gad and Richard to our leadership team reinforce our ability to execute on our ambitious clinical and regulatory goals,” said ...

Leading Sheffield-based pharmaceutical company, B. Braun Medical, announces that its HR Director, Helene Ghosh, has been honoured with the title of Freeman of the Company of Cutlers in Hallamshire ...

Leading Sheffield-based pharmaceutical company, B. Braun Medical, announces that its HR Director, Helene Ghosh, has been honoured with the title of Freeman of the Company of Cutlers in Hallamshire ...

During his tenure as Takeda’s first non-Japanese CEO, Weber expanded the company's international reach with its $62 billion acquisition of Shire. It was through that deal that Kim joined Takeda.

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co ... subject to shareholder approval, the company said in a statement Wednesday.

Weber, 59, has led the Japanese pharma company for more than a decade, most notably steering its $62 billion acquisition of Shire Pharmaceuticals in 2019. He will be replaced by Julie Kim ...

TOKYO, Jan 30 (Reuters) - Takeda Pharmaceutical (4502.T ... joined the company in 2019 along with the acquisition of Shire. She was the head of Takeda's plasma-derived therapies unit before ...

The Ghana Health Service (GHS) has called for local resource mobilization and empowerment of indigenous pharmaceutical companies to produce medications for the treatment of Neglected Tropical Diseases ...

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's ...

was quickly tapped to assume the helm at the newly formed U.S. company, while Shire itself was acquired by Japanese pharma Takeda in 2019. Shortly after assuming his new role, Lee told Fierce ...

a law firm whose specialties include pursuing pharmaceutical drug injury cases. Ethics records released Wednesday indicate that Kennedy intends to keep collecting fees related to past referrals of ...